Vaccines against avian influenza - A race against time.

被引：57

作者：

Poland, GA ^{[1
]}

机构：

[1] Mayo Clin, Coll Med, Mayo Vaccine Res Grp, Rochester, MN 55905 USA

[2] Mayo Clin, Coll Med, Program Translat Immunovirol & Biodef, Rochester, MN USA

[3] Mayo Clin, Coll Med, Dept Internal Med, Rochester, MN USA

来源：

NEW ENGLAND JOURNAL OF MEDICINE | 2006年 / 354卷 / 13期

关键词：

D O I：

10.1056/NEJMe068047

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：1411 / 1413

页数：3

共 14 条

[1] Risk of influenza A (H5N1) infection among health care workers exposed to patients with influenza A (H5N1), Hong Kong [J].

Bridges, CB ;

Katz, JM ;

Seto, WH ;

Chan, PKS ;

Tsang, D ;

Ho, W ;

Mak, KH ;

Lim, W ;

Tam, JS ;

Clarke, M ;

Williams, SG ;

Mounts, AW ;

Bresee, JS ;

Conn, LA ;

Rowe, T ;

Hu-Primmer, J ;

Abernathy, RA ;

Lu, XH ;

Cox, NJ ;

Fukuda, K .

JOURNAL OF INFECTIOUS DISEASES, 2000, 181 (01) :344-348

[2]

Congressional Budget Office, 2005, A Potential Influenza Pandemic: Possible Macroeconomic Effects and Policy Issues

[3] Brief report - Oseltamivir resistance during treatment of influenza A (H5N1) infection [J].

de Jong, MD ;

Thanh, TT ;

Khanh, TH ;

Hien, VM ;

Smith, GJD ;

Chau, NV ;

Cam, BV ;

Qui, PT ;

Ha, DQ ;

Guan, Y ;

Peiris, JSM ;

Hien, TT ;

Farrar, J .

NEW ENGLAND JOURNAL OF MEDICINE, 2005, 353 (25) :2667-2672

[4] Immunogenicity of a monovalent, aluminum-adjuvanted influenza whole virus vaccine for pandemic use [J].

Hehme, N ;

Engelmann, H ;

Kuenzel, W ;

Neumeier, E ;

Saenger, R .

VIRUS RESEARCH, 2004, 103 (1-2) :163-171

[5] Pandemic preparedness:: lessons learnt from H2N2 and H9N2 candidate vaccines [J].

Hehme, N ;

Engelmann, H ;

Künzel, W ;

Neumeier, E ;

Sänger, R .

MEDICAL MICROBIOLOGY AND IMMUNOLOGY, 2002, 191 (3-4) :203-208

[6] Development of adenoviral-vector-based pandemic influenza vaccine against antigenically distinct human H5N1 strains in mice [J].

Hoelscher, MA ;

Garg, S ;

Bangari, DS ;

Belser, JA ;

Lu, XH ;

Stephenson, I ;

Bright, RA ;

Katz, JM ;

Mittal, SK ;

Sambhara, S .

LANCET, 2006, 367 (9509) :475-481

[7] Antibody response in individuals infected with avian influenza A (H5N1) viruses and detection of anti-H5 antibody among household and social contacts [J].

Katz, JM ;

Lim, W ;

Bridges, CB ;

Rowe, T ;

Hu-Primmer, J ;

Lu, XH ;

Abernathy, RA ;

Clarke, M ;

Conn, L ;

Kwong, H ;

Lee, M ;

Au, G ;

Ho, YY ;

Mak, KH ;

Cox, NJ ;

Fukuda, K .

JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (06) :1763-1770

[8] Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza [J].

Nicholson, KG ;

Colegate, AE ;

Podda, A ;

Stephenson, I ;

Wood, J ;

Ypma, E ;

Zambon, MC .

LANCET, 2001, 357 (9272) :1937-1943

[9] Lethal avian influenza A (H5N1) infection in a pregnant woman in Anhui Province, China [J].

Shu, YL ;

Yu, HJ ;

Li, DX .

NEW ENGLAND JOURNAL OF MEDICINE, 2006, 354 (13) :1421-1422

[10] Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population [J].

Stephenson, I ;

Nicholson, KG ;

Colegate, A ;

Podda, A ;

Wood, J ;

Ypma, E ;

Zambon, M .

VACCINE, 2003, 21 (15) :1687-1693

← 1 2 →